EE200300587A - Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine - Google Patents

Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Info

Publication number: EE200300587A
Authority: EE; Estonia
Prior art keywords: preparation; pharmaceutical composition; liquid pharmaceutical; liquid; composition
Prior art date: 2001-05-25

Application number

EEP200300587A

Other languages

English (en)

Estonian (et)

Inventor

Mahesh Kulkarni Neema

Schneider Michael

Bernard Silbering Steven

Richard Meyer-Wonnay Hans

Sanii-Yahyai Nahid

Original Assignee

Warner-Lambert Company Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2002-04-29

Publication date

2004-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300587(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-29 Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc

2004-02-16 Publication of EE200300587A publication Critical patent/EE200300587A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

EEP200300587A 2001-05-25 2002-04-29 Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine EE200300587A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29383201P	2001-05-25	2001-05-25
US34373301P	2001-10-25	2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en)	2001-05-25	2002-04-29	Liquid pharmaceutical composition

Publications (1)

Publication Number	Publication Date
EE200300587A true EE200300587A (et)	2004-02-16

Family

ID=26968180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300587A EE200300587A (et)	2001-05-25	2002-04-29	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Country Status (43)

Country	Link
US (2)	US20020198261A1 (xx)
EP (1)	EP1395242B1 (xx)
JP (1)	JP2004534764A (xx)
KR (1)	KR100582963B1 (xx)
CN (1)	CN100346779C (xx)
AP (1)	AP1815A (xx)
AR (1)	AR033922A1 (xx)
AT (1)	ATE334656T1 (xx)
AU (1)	AU2002258026B2 (xx)
BG (1)	BG108376A (xx)
BR (1)	BR0209973A (xx)
CA (1)	CA2446574C (xx)
CR (1)	CR7150A (xx)
CY (1)	CY1105147T1 (xx)
CZ (1)	CZ299755B6 (xx)
DE (1)	DE60213592T2 (xx)
DK (1)	DK1395242T3 (xx)
DO (1)	DOP2002000403A (xx)
EA (1)	EA008087B1 (xx)
EE (1)	EE200300587A (xx)
EG (1)	EG24078A (xx)
ES (1)	ES2265040T3 (xx)
GE (1)	GEP20053620B (xx)
HR (1)	HRP20030833B1 (xx)
HU (1)	HUP0401366A2 (xx)
IL (1)	IL158359A0 (xx)
IS (1)	IS2428B (xx)
MA (1)	MA27026A1 (xx)
MX (1)	MXPA03009392A (xx)
MY (1)	MY128615A (xx)
NO (1)	NO20035200D0 (xx)
NZ (1)	NZ529173A (xx)
OA (1)	OA12604A (xx)
PA (1)	PA8545901A1 (xx)
PE (1)	PE20030087A1 (xx)
PL (1)	PL366384A1 (xx)
PT (1)	PT1395242E (xx)
RS (1)	RS87203A (xx)
SI (1)	SI1395242T1 (xx)
SK (1)	SK286227B6 (xx)
SV (1)	SV2003001053A (xx)
WO (1)	WO2002094220A1 (xx)
ZA (1)	ZA200308393B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100491282B1 (ko)	1996-07-24	2005-05-24	워너-램버트 캄파니 엘엘씨	통증 치료용 이소부틸가바 및 그의 유도체
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
AU2003250481A1 (en) *	2002-08-15	2004-03-03	Pfizer Inc.	Therapeutic use of fused bicyclic or tricyclic amino acids
RU2353358C2 (ru) *	2002-12-13	2009-04-27	Уорнер-Ламберт Компани Ллс	Производные прегабалина для лечения приливов
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
ES2288641T3 (es) *	2002-12-20	2008-01-16	Dynogen Pharmaceuticals Inc.	Metodo para tratar trastornos indoloros de la vejiga usando moduladores de canales del calcio de la subunidad alfa2-delta.
US7169812B2 (en) *	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
WO2005025675A1 (en) *	2003-09-12	2005-03-24	Pfizer Limited	Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
EP1680144B1 (en) *	2003-10-08	2011-10-05	Mallinckrodt LLC	Methylphenidate solution and associated methods of administration and production
US20050090549A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of pain
US20050090548A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of epilepsy
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
DE102004015752B4 (de) *	2004-03-31	2007-04-05	Christian-Albrechts-Universität Zu Kiel	Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
KR100870381B1 (ko) *	2004-10-14	2008-11-25	다이킨 고교 가부시키가이샤	분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
CA2618481A1 (en) *	2005-08-11	2007-02-15	Boehringer Ingelheim International Gmbh	Compounds for treating alzheimer's disease
EP1915353A2 (de) *	2005-08-11	2008-04-30	Boehringer Ingelheim International GmbH	Isophthalsäurediamide zur behandlung der alzheimer erkrankung
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
EP2116618A1 (en) *	2008-05-09	2009-11-11	Agency for Science, Technology And Research	Diagnosis and treatment of Kawasaki disease
EP2246044A1 (en) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Paediatric solutions comprising a beta-blocker
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) *	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种治疗儿童癫痫药物口服乳剂及其制备方法
WO2018167628A1 (en)	2017-03-13	2018-09-20	Ftf Pharma Private Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
EP3668508A1 (en)	2017-08-19	2020-06-24	FTF Pharma Private Limited	An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
WO2019186515A1 (en) *	2018-03-30	2019-10-03	Ftf Pharma Private Limited	Liquid pharmaceutical compositions of antiepileptic drugs
CN112566625A (zh) *	2018-08-18	2021-03-26	夫特弗制药私人有限公司	口服剂量的化学治疗药物悬浮液
GB2591396B (en)	2018-08-18	2023-06-07	Ftf Pharma Private Ltd	Pharmaceutical suspension for oral dosage
US20220175707A1 (en)	2019-03-26	2022-06-09	Orion Corporation	Pregabalin formulations and use thereof
HU231397B1 (hu)	2021-01-22	2023-06-28	Egis Gyógyszergyár Zrt.	Pregabalint tartalmazó topikális gyógyszerkészítmény
CA3208954A1 (en)	2021-01-22	2022-07-28	Egis Gyogyszergyar Zrt.	Topical formulation containing modified phospholipid compounds
WO2022168968A1 (ja) *	2021-02-05	2022-08-11	学校法人近畿大学	末梢神経障害の予防又は改善剤
EP4395758A4 (en) *	2021-08-31	2025-07-30	Avion Pharmaceuticals Llc	STABLE GABAPENTIN POWDER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
CN1303991C (zh) *	1998-05-15	2007-03-14	沃尼尔·朗伯公司	γ－氨基丁酸衍生物的稳定药物制剂和其制备方法
PL365927A1 (en) *	2000-11-30	2005-01-10	Pfizer Products Inc.	Combination of gaba agonists and sorbitol dehydrogenase inhibitors

2002
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en not_active Ceased
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-04-29 EP EP02727834A patent/EP1395242B1/en not_active Expired - Lifetime
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 EE EEP200300587A patent/EE200300587A/xx unknown
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active Expired - Fee Related
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200D0/no not_active Application Discontinuation
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown

Also Published As

Publication number	Publication date
CZ20033066A3 (cs)	2004-08-18
BR0209973A (pt)	2004-04-06
SI1395242T1 (en)	2006-10-31
RS87203A (sr)	2006-10-27
GEP20053620B (en)	2005-09-26
CA2446574A1 (en)	2002-11-28
DOP2002000403A (es)	2002-11-30
MXPA03009392A (es)	2004-01-29
PT1395242E (pt)	2006-11-30
AP1815A (en)	2008-01-04
MA27026A1 (fr)	2004-12-20
JP2004534764A (ja)	2004-11-18
PA8545901A1 (es)	2003-09-05
EP1395242A1 (en)	2004-03-10
IS6986A (is)	2003-10-09
EG24078A (en)	2008-05-11
CA2446574C (en)	2008-04-01
CN1509165A (zh)	2004-06-30
MY128615A (en)	2007-02-28
ATE334656T1 (de)	2006-08-15
US7256216B2 (en)	2007-08-14
AP2003002907A0 (en)	2003-12-31
CZ299755B6 (cs)	2008-11-12
KR20040003006A (ko)	2004-01-07
IL158359A0 (en)	2004-05-12
EP1395242B1 (en)	2006-08-02
PL366384A1 (en)	2005-01-24
BG108376A (bg)	2005-04-30
HUP0401366A2 (hu)	2004-11-29
ES2265040T3 (es)	2007-02-01
IS2428B (is)	2008-10-15
HRP20030833B1 (en)	2007-04-30
CR7150A (es)	2004-02-23
US20020198261A1 (en)	2002-12-26
DK1395242T3 (da)	2006-10-30
EA008087B1 (ru)	2007-02-27
ZA200308393B (en)	2005-04-26
EA200301152A1 (ru)	2004-04-29
SK286227B6 (sk)	2008-05-06
US20040072904A1 (en)	2004-04-15
CN100346779C (zh)	2007-11-07
HRP20030833A2 (en)	2004-08-31
DE60213592D1 (de)	2006-09-14
KR100582963B1 (ko)	2006-05-24
PE20030087A1 (es)	2003-02-14
AU2002258026B2 (en)	2007-08-02
NO20035200L (no)	2003-11-24
HK1062646A1 (zh)	2004-11-19
DE60213592T2 (de)	2007-08-09
SK14112003A3 (sk)	2004-08-03
CY1105147T1 (el)	2010-03-03
NZ529173A (en)	2005-07-29
SV2003001053A (es)	2003-03-18
OA12604A (en)	2006-06-08
WO2002094220A1 (en)	2002-11-28
AR033922A1 (es)	2004-01-07
NO20035200D0 (no)	2003-11-24

Publication	Publication Date	Title
EE200300587A (et)	2004-02-16	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE200300236A (et)	2003-08-15	1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300581A (et)	2004-02-16	Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200200487A (et)	2004-02-16	Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200300171A (et)	2003-06-16	Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE05475B1 (et)	2011-10-17	Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE200300370A (et)	2003-10-15	Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200400028A (et)	2004-04-15	Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
NO20031273L (no)	2003-05-14	Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
IS6378A (is)	2002-05-10	Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
PL394600A1 (pl)	2011-07-18	Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
EE05175B1 (et)	2009-06-15	Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
EE200300488A (et)	2003-12-15	Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
EE200300255A (et)	2003-08-15	Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
NO326689B1 (no)	2009-01-26	Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
EE04346B1 (et)	2004-08-16	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0401107A3 (en)	2004-10-28	Novel benzo-fused heterocycles, their use process for their preparation and pharmaceutical compositions containing them
EE200200199A (et)	2003-06-16	N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE04902B1 (et)	2007-10-15	Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EE200100662A (et)	2003-04-15	Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine